FN1 and neoplasm: Moreover, on the stromal tumor side, Fn binding to the T lymphocyte inhibitory receptors TIGIT and CEACAM-1 (via Fap-2 and the trimeric autotransporter adhesin CbpF, respectively [11]) suppresses antitumor immunity, thereby indirectly promoting malignant growth [12,13].